Crossmark

Costs of stereotactic ablative radiotherapy compared to conventional radiotherapy in the treatment of non-small cell lung cancer – a micro-costing study using Time-Driven Activity Based Costing (TDABC)

Crossref DOI link: https://doi.org/10.1186/s12913-024-11969-y

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Albuquerque Maia, Fernando Henrique https://orcid.org/0000-0001-7227-9774
da Conceição Vasconcelos, Karina Gondim Moutinho https://orcid.org/0000-0001-9544-6555
de Andrade Carvalho, Heloisa https://orcid.org/0000-0003-0979-7768
de Soárez, Patrícia Coelho https://orcid.org/0000-0001-8383-0728
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 27 May 2024

Accepted: 18 November 2024

First Online: 26 November 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below